| | Report | Presentation | Webcast |
| December 9, 2020Interim Report May – October 2020 – Report | | | |
| December 3, 2020Oasmia’s Partner Elevar Provides an Update on Apealea Development Plans in Ovarian Cancer | | | |
| November 11, 2020Investival Showcase 11-16 November 2020, Virtual Conference | | | |
| October 29, 2020BIO-Europe®, Virtual Conference | | | |
| October 7, 2020Oasmia Erik Penser Cancer Day Presentation | | | |
| September 24, 2020Oasmia Erik Penser Investor Event Presentation | | | |
| September 21, 2020Presentation at Sachs Biotech in Europe Forum | | | |
| September 15, 2020Aktiedagen Digitalt | | | |
| September 9, 2020Interim Report May – July 2020 | | | |
| August 19, 2020Annual Report 2019 / 2020 | | | |
| July 30, 2020Analysguiden: Interview with Oasmia | | | |
| June 18, 2020Year-end Report 2019 / 2020 | | | |
| June 10, 2020Company Presentation Aktiespararna | | | |
| June 3, 2020Avanza Börsdag | | | |
| May 13, 2020Strategic Review Presentation | | | |
| March 27, 2020Interim Report May 2019 – January 2020 | | | |
| March 25, 2020Elevar deal | | | |
| February 14, 2020Oasmia appoints new CEO | | | |
